Trimax Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 36.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 31.95 Cr
as on 14-12-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 33.81 Cr
as on 14-12-2024
- Revenue 1.99%
(FY 2021)
- Profit -40.75%
(FY 2021)
- Ebitda -12.20%
(FY 2021)
- Net Worth 1.74%
(FY 2021)
- Total Assets 2.59%
(FY 2021)
About Trimax Bio Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 36.00 Cr and a paid-up capital of Rs 31.95 Cr.
The company has closed loans amounting to ₹33.81 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Trimax Bio Sciences Private Limited India is Battu Raj as COMPANY SECRETARY. Chebrolu Krishna, Amit Sinha, Nageswara Karusala, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24297TG2010PTC068376
- Company No.
068376
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Trimax Bio Sciences Private Limited offer?
Trimax Bio Sciences Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Alcohol Solvents, Antihistamines, Meclizine HCL, Ethanol.
Who are the key members and board of directors at Trimax Bio Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Sinha  | Managing Director | 09-Jan-2024 | Current |
| Battu Raj | Company Secretary | 08-Jun-2019 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chebrolu Krishna | Director | 11-May-2010 | Current |
| Nageswara Karusala | Director | 11-May-2010 | Current |
| Swati Sinha | Director | 09-Jan-2024 | Current |
| Subbarami Reddy | Director | 09-Jan-2024 | Current |
| Dhanalakshmi Guntaka | Director | 09-Jan-2024 | Current |
Financial Performance and Corporate Structure Insights of Trimax Bio Sciences.
Trimax Bio Sciences Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 1.99% increase. The company also saw a substantial fall in profitability, with a 40.75% decrease in profit. The company's net worth moved up by a moderate rise of 1.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trimax Bio Sciences?
In 2021, Trimax Bio Sciences had a promoter holding of 64.60% and a public holding of 35.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sigachi Industries LimitedActive 35 years 11 monthsAmit Sinha and Dhanalakshmi Guntaka are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Mar 2019 | ₹7.50 Cr | Satisfied |
Others Creation Date: 28 Mar 2019 | ₹4.00 Cr | Satisfied |
Others Creation Date: 29 Mar 2012 | ₹22.31 Cr | Satisfied |
How Many Employees Work at Trimax Bio Sciences?
Trimax Bio Sciences has a workforce of 113 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trimax Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trimax Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
